An Open-Label, Randomized, Single-Dose, Crossover, Comparative Pharmacokinetics Study of YLB113 and the Etanercept Reference Product in Healthy Adult Male Subjects

被引:0
|
作者
Mustafa Shennak
Rana Al-Jaouni
Santhosh Kshirasagar
Ravi Sekhar Kasibhatta
Neelima Godse
Ahmad Al-Ghazawi
Praveen Vittala
Dhananjay Bakhle
机构
[1] Triumpharma,
[2] Lupin Limited,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:467 / 475
页数:8
相关论文
共 50 条
  • [41] An Open-Label, Single-Dose, Human Mass Balance Study of Amenamevir in Healthy Male Adults
    Kato, Kota
    den Adel, Martin
    Groenendaal-van de Meent, Dorien
    Ohtsu, Yoshiaki
    Takada, Akitsugu
    Katashima, Masataka
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (05): : 595 - 602
  • [42] Pharmacokinetics of a nanocrystal-containing megestrol acetate formulation: a single-dose, randomized, open-label, 2-part, 2-period crossover study in healthy Korean subjects
    Chae, Dong Woo
    Son, Hankil
    Guk, Jinju
    Park, Changhun
    Park, Kyungsoo
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (09) : 698 - 704
  • [43] A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects
    Trivedi, Ashit
    Mather, Omar
    Vega, Silvia
    Hutton, Shauna
    Hellawell, Jennifer
    Lee, Edward
    DRUGS IN R&D, 2022, 22 (02) : 141 - 146
  • [44] A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects
    Ashit Trivedi
    Omar Mather
    Silvia Vega
    Shauna Hutton
    Jennifer Hellawell
    Edward Lee
    Drugs in R&D, 2022, 22 : 141 - 146
  • [45] Pharmacokinetics of AXA1665, a Novel Composition of Amino Acids, in Comparison With Protein Supplement: A Single-Dose, Open-Label, Randomized Study in Healthy Subjects
    Vaidya, Soniya
    McLinden, Joshua
    Hinderliter, Paul
    Tatsuta, Noriaki
    Steinberg, Alexandra
    Rebello, Sam
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (07): : 718 - 730
  • [46] Pharmacokinetics and Bioequivalence Study of Three Oral Formulations of Valsartan 160 mg: A Single-Dose, Randomized, Open-Label, Three-Period Crossover Comparison in Healthy Indian Male Volunteers
    Iqbal, Muzaffar
    Khuroo, Arshad
    Batolar, Lakhvinder S.
    Tandon, Monika
    Monif, Tausif
    Sharma, P. L.
    CLINICAL THERAPEUTICS, 2010, 32 (03) : 588 - 596
  • [47] Single-dose, Randomized, Open-label, 2-way Crossover Study of the Pharmacokinetics of Amitriptyline Hydrochloride 10-and 25-mg Tablet in Healthy Male Korean Volunteers
    Nam, Yunsung
    Lim, Cheol-Hee
    Lee, Ho Sung
    Chung, Su Jin
    Chung, Yoon Hee
    Shin, Yong Kyoo
    Kim, Min-Gul
    Sohn, Uy Dong
    Kim, Hyoung-Chun
    Jeong, Ji Hoon
    CLINICAL THERAPEUTICS, 2015, 37 (02) : 302 - 310
  • [48] An Open-Label, Single-Dose, Parallel-Group, Dose-Increasing Study Comparing the Pharmacokinetics and Tolerability of Pilsicainide Hydrochloride in Healthy Korean and Japanese Male Subjects
    Kim, Bo-Hyung
    Kim, Jung-Ryul
    Lim, Kyoung Soo
    Kim, Jae Woo
    Kim, Kyu-pyo
    Hong, Jang-Hee
    Jang, In-Jin
    Shin, Sang-Goo
    Yu, Kyung-Sang
    Tanaka, Takanori
    CLINICAL THERAPEUTICS, 2009, 31 (03) : 609 - 618
  • [49] Effect of Food on the Pharmacokinetics of Clozapine Orally Disintegrating Tablet 12.5 mgA Randomized,Open-Label,Crossover Study in Healthy Male Subjects
    Anthony R. DiSanto
    Gil Golden
    Clinical Drug Investigation, 2009, 29 : 539 - 549
  • [50] Phase 1, open-label, single-dose study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of futibatinib in adult subjects
    Gao, Ling
    Yamamiya, Ikuo
    Pinti, Mark
    Rondon, Juan Carlos
    Gareth, Thomas Marbury
    Tomlinson, Gareth
    Makris, Lukas
    Hangai, Nanae
    Wacheck, Volker
    CANCER RESEARCH, 2023, 83 (08)